Peking University and universities of Anhui Province and biological medicine joint study found: a name of "homocysteine" are Chinese hypertension new accomplice, it enables patients with stroke (stroke) and the risk of death than healthy population increased 11 times.
Participation in the study of Peking University Professor Hogg Yong held here today "control hypertension prevention stroke" Forum said, "homocysteine in methionine is" human cell metabolism of intermediate products, its content in human blood exceeds a certain concentration, it will damage the vascular endothelial cells, resulting in increased blood clotting process to brain thrombus, bring deadly threats.
From the beginning of the study in 1995, on the Mainland of more than $ 165 for an average of six years of tracking, the results indicate that the simple hypertension or high "homocysteine" of patients, the risk of stroke and death were three times the normal population and four times, and both increase the risk of stroke increases to 12 times. Research data show: Chinese hypertension patients about 75 per cent with "homocysteine" rise up to 60%, females, males up to 91.
Prof Fok, reducing the material most safe and effective way to supplement of folic acid. In June last year, and US experts in the Lancet published jointly by the supplement of folic acid to prevent stroke effect of meta-analyses of proposed: Supplement of folic acid can enable "homocysteine" decline more than 20 per cent, thereby decreasing the risk of stroke by 25%.
World hypertension League President, fuwai hospital Professor Liu students emphasized that China is about the incidence of stroke middle age 25 per 100 000, the annual incidence of coronary heart disease for about ten thousandths, the ratio of two to five to one; and cerebrovascular disease prevention focuses on the prevention of stroke; and Chinese hypertension "homocysteine" increase universality, so it may become lower control stroke and an important means of high-fat.
Prof. Liu, according to multiple risk factors and control concept, Government health and drug administration departments should support related compound medicine research and development and clinical application, to improve patient compliance in long-term treatment, to reduce the incidence of stroke and death.
(Edit: 1m1m responsible gavin)
No comments:
Post a Comment